Boston-based startup Sano LLC seeks $1 million in seed funding to commercialize its chronic wound diagnostic in 2015. The recent winner of M2D2 aims to bring the diagnostic to market at a price point as low as a home pregnancy test. While Woundchek has a CE Mark, American physicians are left with a pretty basic tool kit for wound treatment: sniffing for foul odor, looking at the color and how much liquid the wound is producing and considering the amount of granulation in the tissue. Sano LLC CEO Paul Hayre said Sano wants to “bring in a little bit of science to the art of wound care.”
Hey, check out all the engineering jobs. Post your resume today!
